These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35784397)

  • 41. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of liver metastases radiomic feature reproducibility with deep-learning-based semi-automatic segmentation software.
    Wang L; Tan J; Ge Y; Tao X; Cui Z; Fei Z; Lu J; Zhang H; Pan Z
    Acta Radiol; 2021 Mar; 62(3):291-301. PubMed ID: 32517533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic accuracy of the placenta accreta index for placenta accreta spectrum: A prospective study.
    Abu Hashim H; Shalaby EM; Hussien MH; El Rakhawy M
    Int J Gynaecol Obstet; 2022 Jan; 156(1):71-76. PubMed ID: 33471360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of success of uterus-preserving management in women with placenta accreta spectrum (CON-PAS score): A multicenter international study.
    Shazly SA; Hortu I; Shih JC; Melekoglu R; Fan S; Ahmed FUA; Karaman E; Fatkullin I; Pinto PV; Irianti S; Tochie JN; Abdelbadie AS; Salah MA; Elazeem HASA; Saad MM; Ergenoglu AM; Yeniel AO; Sagol S; Itil IM; Kang J; Huang KY; Yilmaz E; Liang Y; Aziz H; Akhter T; Ambreen A; Ateş Ç; Karaman Y; Khasanov A; Fatkullina L; Akhmadeev N; Vatanina A; Machado AP; Montenegro N; Effendi JS; Suardi D; Pramatirta AY; Aziz MA; Siddiq A; Ofakem I; Dohbit JS; Fahmy MS; Anan MA
    Int J Gynaecol Obstet; 2021 Aug; 154(2):304-311. PubMed ID: 33278833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of placenta accreta spectrum using texture analysis on coronal and sagittal T2-weighted imaging.
    Ren H; Mori N; Mugikura S; Shimizu H; Kageyama S; Saito M; Takase K
    Abdom Radiol (NY); 2021 Nov; 46(11):5344-5352. PubMed ID: 34331104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of intrapelvic parasitic arteries in patients with placenta accreta spectrum: A case-control study using unenhanced magnetic resonance angiography.
    Mori K; Saida T; Hoshiai S; Shibuya Y; Obata-Yasuoka M; Ishiguro T; Takahashi H; Hamada H; Sato T; Minami M
    Clin Imaging; 2020 Jul; 63():50-56. PubMed ID: 32143124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
    Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
    van Beekhuizen HJ; Stefanovic V; Schwickert A; Henrich W; Fox KA; MHallem Gziri M; Sentilhes L; Gronbeck L; Chantraine F; Morel O; Bertholdt C; Braun T; Rijken MJ; Duvekot JJ;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1(Suppl 1):12-20. PubMed ID: 33483943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion MRI Based Myometrium Tractography for Detection of Placenta Accreta Spectrum Disorder.
    Yan G; Liao Y; Li K; Zhang X; Zheng W; Zhang Y; Zou Y; Chen D; Wu D
    J Magn Reson Imaging; 2022 Jan; 55(1):255-264. PubMed ID: 34155718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic Resonance Imaging of Placenta Accreta Spectrum: A Step-by-Step Approach.
    Srisajjakul S; Prapaisilp P; Bangchokdee S
    Korean J Radiol; 2021 Feb; 22(2):198-212. PubMed ID: 33169550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of care for women with placenta accreta spectrum.
    Couret M; Huang Y; Khoury-Collado F; Friedman A; Hou JY; St Clair CM; Tergas AI; Ananth CV; Wright JD
    J Matern Fetal Neonatal Med; 2021 Oct; 34(20):3370-3376. PubMed ID: 31744356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.
    Tinari S; Buca D; Cali G; Timor-Tritsch I; Palacios-Jaraquemada J; Rizzo G; Lucidi A; Di Mascio D; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):903-909. PubMed ID: 32840934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRI-Based Radiomics Analysis for Intraoperative Risk Assessment in Gravid Patients at High Risk with Placenta Accreta Spectrum.
    Chu C; Liu M; Zhang Y; Zhao S; Ge Y; Li W; Gao C
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders.
    Einerson BD; Rodriguez CE; Kennedy AM; Woodward PJ; Donnelly MA; Silver RM
    Am J Obstet Gynecol; 2018 Jun; 218(6):618.e1-618.e7. PubMed ID: 29572089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer.
    Hodneland E; Kaliyugarasan S; Wagner-Larsen KS; Lura N; Andersen E; Bartsch H; Smit N; Halle MK; Krakstad C; Lundervold AS; Haldorsen IS
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of pregnancies at high-risk for placenta accreta spectrum following negative diagnostic imaging.
    Reeder CF; Sylvester-Armstrong KR; Silva LM; Wert EM; Smulian JC; Genc MR
    J Perinat Med; 2022 Jun; 50(5):595-600. PubMed ID: 35218171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR Images.
    Sunoqrot MRS; Selnæs KM; Sandsmark E; Langørgen S; Bertilsson H; Bathen TF; Elschot M
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome.
    Palacios-Jaraquemada JM; D'Antonio F; Buca D; Fiorillo A; Larraza P
    J Matern Fetal Neonatal Med; 2020 Oct; 33(19):3377-3384. PubMed ID: 30700221
    [No Abstract]   [Full Text] [Related]  

  • 60. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.